Scientific Advisory Board

Deurion LLC is a privately held company founded in 2011 to operate in the life sciences sector. Our expertise is in Biological Mass Spectrometry, Bioinformatics, and Microfluidics. Headquartered in Seattle, WA with operations in Baltimore, MD.

Scientific Advisory Board

Dr. David R. Goodlett, Ph.D.

Professor, University of Maryland School of Pharmacy. Prof Goodlett currently holds the Isaac E. Emerson Chair in Pharmaceutical Sciences. He is also serving a four year term as a Finland Distinguished Professor at the University of Turku in Turku, Finland. Prior to moving to Baltimore he was in Seattle, WA for nearly twenty years where he was Professor of Medicinal Chemistry at the University of Washington for nine years and prior to that was the Director of Proteomics at the Institute of Systems Biology. His post-doctoral training was with Dr. Richard D. Smith after which he spent five years in the pharmaceutical industry before coming back to academic research.

 

Dr. Patrick R.R Langridge-Smith, Ph.D.

Reader in Chemical Physics at the University of Edinburgh. Founder and Director of the Scottish Instrumentation and Resource Centre for Advanced Mass Spectrometry (SIRCAMS) in the School of Chemistry. Significant advances have been made by Dr Langridge-Smith’s research group, the Exploratory Measurement Science Group (EMSG), in the development of novel MS platforms, including a collaboration with HD Technology Ltd. which eventually led to the development of the Orbitrap mass spectrometer, now marketed by Thermo Fisher Scientific. He was elected as a Fellow of the Institute of Physics in 2000.

 

Mr. Erik Nilsson

Erik Nilsson currently serves as CEO of Deurion. He continues to also lead Insilicos, a Seattle based software development company, where he is responsible for strategic direction. Mr. Nilsson has a software background spanning two decades includes management, software technology, and sales and marketing. Prior to Insilicos, Mr. Nilsson was president of software company GraphiCode, which he sold in 1999 to Mania Technologie AG. Mr. Nillson then served as a division president for Mania, managing a software development and sales organization spanning three continents. Mr. Nilsson was Director of Sales and Marketing for Solution Logic. Erik’s experience also includes positions at Tektronix and Mitron. Mr. Nilsson is also a member of the board of the Washington Biotech and Biomedical Association. He sits on the Executive Committee, and chairs the Government Affairs Council.